论文部分内容阅读
目的探讨分析子宫内膜息肉宫腔镜手术后甾体激素治疗的临床疗效。方法将80例于2014年1月~3月在四川省人民医院妇科住院接受宫腔镜下子宫内膜息肉电切手术且术后病理检查确诊为子宫内膜息肉的育龄期妇女随机分配为两组﹐每组40例。观察组﹕术后不采取任何特殊治疗。药物治疗组﹕术后立即开始服用屈螺酮炔雌醇片(优思明)治疗6个月。结果术后6个月复查观察组6例B 超提示子宫内膜息肉复发﹐药物治疗组1例B 超提示子宫内膜息肉复发﹐两组的复发率存在明显统计学差异(=3.91﹐<0.05)﹐术后12个月复查观察组13例B 超提示子宫内膜息肉复发﹐药物治疗组2例B 超提示子宫内膜息肉复发﹐两组的复发率存在明显统计学差异(=9.93﹐<0.005)。术后6个月复查观察组30例患者症状明显缓解(75﹪)﹐药物治疗组39例患者症状明显缓解(97.5﹪)﹔两组比较有明显统计学差异(=8.54﹐<0.005)。术后12个月复查观察组25例患者完全治愈﹐药物治疗组36例患者完全治愈﹔两组比较有明显统计学差异(=8.35﹐<0.005)。结论宫腔镜术后联合应用屈螺酮炔雌醇片治疗子宫内膜息肉能有效预防息肉复发﹐巩固治疗效果﹐且安全可靠﹐值得推广。“,”Objective To investigate the clinical efficacy of steriod hormone in treating endometrial polyps after hysteroscopic operation. Methods 80 patients with diagnosis of uterine endometrial polyps patients during january-march of 2014, randomly divided into observation group and drug(steriod hormone)-treating group,the patients in observation group only received hysteroscopic operation treatment,drug group were given drospirenone and ethinylestradiol tablets for 6 months after operation. Results The number of recurrence of drug group compared with the observation group had significant difference after 6 and 12months( =3.91 <0.05, =9.93 <0.005). Thel remission rate of the patients in the drug group was 97.5%, and 75% in the observation group ( =8.54 P<0.005) after 6 months. The recovery rate of the drug group was 90% was significantly higher than that of the observation group which was 62.5%( =8.35 <0.005).Conclusion Hysteroscopy operation combined with drospirenone and ethinylestradiol tablets significantly decrease the recurrence of endometrial polyps and control clinical symptoms, it deserved using widely because of its safty and efficiency.